Skip to main navigation Skip to search Skip to main content

How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic transcatheter aortic valve implantation?

  • Stephane Fournier
  • , Pierre Monney
  • , Christian Roguelov
  • , Enrico Ferrari
  • , Eric Eeckhout
  • , Olivier Muller*
  • , Andras Durko
  • , Nicolas M. van Mieghem
  • , Arie Pieter Kappetein
  • , Ronan Margey
  • *Corresponding author for this work
  • University of Lausanne
  • Cardiocentro Ticino Foundation
  • Erasmus MC
  • Mater Private Hospital

Research output: Contribution to journalReview articleAcademicpeer-review

2 Downloads (Pure)

Abstract

BACKGROUND: A 91-year-old gentleman with a symptomatic severe aortic valve stenosis and chronic kidney disease was referred to our hospital for evaluation. INVESTIGATION: Valve area: 0.5 cm2 with a mean transaortic gradient of 52 mmHg. EuroSCORE II: 15.24% and STS score: 10%. The Heart Team decided to implant a balloon-expandable Edwards SAPIEN 3 transcatheter valve via a transaortic approach (important peripheral disease). DIAGNOSIS: During inflation, the Edwards SAPIEN 3 valve expanded asymmetrically and embolised in the ascending aorta where it remained stuck onto the outside lumen of the sheath in a half-deployed conformation. MANAGEMENT: After different manoeuvres, the valve was successfully uncoupled from the sheath but a complete valve expansion had to be performed, leaving the valve floating in the ascending aorta. Using a transfemoral route, the valve was captured and inflated in the aortic arch.
Original languageEnglish
Pages (from-to)495-498
JournalEuroIntervention
Volume13
Issue number4
DOIs
Publication statusPublished - 1 Jul 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic transcatheter aortic valve implantation?'. Together they form a unique fingerprint.

Cite this